Answers are grounded in this paper and cite their sources.
Among participants with dementia, the prevalence of amyloid positivity was associated with clinical diagnosis, age, and APOE genotype. These findings indicate the potential clinical utility of amyloid imaging for differential diagnosis in early-onset dementia and to support the clinical diagnosis of participants with AD dementia and noncarrier APOE ε4 status who are older than 70 years.
No takes yet. Share an insight, caveat, or question.
Ossenkoppele et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: